Search Results for covid-19

COVID-19 vaccine manufacturers produced more than 11 billion doses in 2021

Since the onset of the COVID-19 pandemic, vaccine manufacturers, regulatory agencies, and governments have collaborated to produce COVID-19 vaccines. Starting with a few hundred million doses in January 2021, production increased to over 12 billion doses by the end of that same year. This increase was enabled by expanding production facilities and initiating certain components of manufacturing efforts before vaccine authorization.

Flawed analysis by Peter McCullough and others used to promote baseless claim that brain blood clots “112,000% more likely” after COVID-19 vaccine than flu vaccine

Since 2021, certain COVID-19 vaccines, specifically the viral vector COVID-19 vaccines, have been linked to a rare blood clotting problem known as thrombosis with thrombocytopenia syndrome. But COVID-19 mRNA vaccines aren’t associated with the same risk. COVID-19 vaccines are highly effective at reducing the risk of severe disease and death. Getting COVID-19 is associated with a much greater risk of blood clots than getting the vaccine. On balance, the vaccines’ benefits outweigh their risks.

Japanese government didn’t declare COVID-19 mRNA vaccines to be deadly

COVID-19 vaccines are safe and effective in preventing severe illness, hospitalization, and death from the virus. They’ve been rigorously tested via clinical trials and are routinely monitored by health agencies for safety. While rare side effects such as myocarditis (inflammation of the heart) and blood clotting disorders have been reported, these events are uncommon. COVID-19 itself is more likely to increase the risk of heart inflammation and blood clotting than vaccines. The benefits of vaccination outweigh the potential risks.

Peter McCullough misleads again about the benefits and risks of COVID-19 vaccines in viral interview

COVID-19 vaccines are the safest way of reducing the likelihood of getting severely ill or dying from COVID-19. However, they are associated with some risks; for example, viral vector vaccines are associated with rare cases of blood clotting, and mRNA COVID-19 vaccines are associated with a slightly increased risk of heart inflammation in young males. But COVID-19 itself carries a much higher risk of developing blood clots and cardiovascular problems than vaccination. By lowering these risks, the benefits of COVID-19 vaccination outweigh the small risk of serious side effects.

Peter McCullough’s claim that COVID-19 vaccines might have caused rise in sudden deaths relies on flawed analysis

mRNA COVID-19 vaccines are associated with a slightly elevated risk of myocarditis in young males. However, such cases are very rare and not associated with an increased risk of death. COVID-19 itself is a much more likely cause of hospitalization and death from myocarditis and other complications. Therefore, vaccinating is the best way of reducing these potential risks, a benefit that far exceeds the low likelihood of developing myocarditis after vaccination.

Higher COVID-19 death toll under Biden than Trump reflects longer presidential term spent managing the COVID-19 pandemic

As of September 2024, COVID-19 was responsible for 1.2 million deaths in the U.S., with the majority of those deaths occurring during Biden’s presidency. However, death toll figures under both the Trump and Biden administrations aren’t directly comparable because Biden has been in office for a longer period of time since the virus emerged compared to Trump. Once we account for the duration of each administration, the weekly COVID-19 mortality rate was lower on average during the period coinciding with Biden’s presidency.

People experiencing homelessness died more frequently from COVID-19 than the general population

People experiencing homelessness represent a vulnerable segment of the population. They face difficulty accessing resources like food, shelter, and healthcare. Available data on COVID-19 outcomes in this group indicate that they died at a higher rate than the general population. This can be explained in part by a higher prevalence of COVID-19 comorbidities, such as diabetes and cardiovascular conditions.